Insider Transactions in Q4 2020 at Sarepta Therapeutics, Inc. (SRPT)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Douglas S Ingram President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,144
-9.4%
|
$6,314,480
$170.49 P/Share
|
|
Dec 11
2020
|
Joseph Bratica Principal Financial Officer |
SELL
Open market or private sale
|
Direct |
1,115
-12.05%
|
$183,975
$165.0 P/Share
|
|
Dec 11
2020
|
Joseph Bratica Principal Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,115
+10.75%
|
$79,165
$71.45 P/Share
|
|
Dec 10
2020
|
Mary Ann Gray Director |
BUY
Exercise of conversion of derivative security
|
Direct |
967
+14.48%
|
-
|
|
Dec 08
2020
|
Joseph Bratica Principal Financial Officer |
SELL
Open market or private sale
|
Direct |
1,125
-12.14%
|
$180,000
$160.0 P/Share
|
|
Dec 08
2020
|
Joseph Bratica Principal Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+10.83%
|
$32,625
$29.6 P/Share
|